The following paper by Fernández del Río et al. (2015) reports on breath analysis to detect liver cirrhosis, which is an advanced stage of hepatic fibrosis that is caused by several conditions, primarily viral hepatitis and chronic alcohol abuse (Byass, 2014) . Presently, the detection of liver disease is commonly made by blood tests targeting liver function enzymes, with subsequent biopsy if test results indicate high levels. Symptoms are often presented late in the course of the disease, which considerably reduces the chances of survival. In terms of prevalence and mortality rates, worldwide liver cirrhosis mortality was estimated at just over one million in 2010 (~2% of the global total) (Mokdad et al., 2014) , it was listed as the twelfth leading cause of death in the USA (almost 32,000 deaths, or 1.3% of total deaths) (Murphy et al., 2013) and is on the rise in countries such as the UK, where its prevalence in terms of premature mortality increased substantially (by 65%) between 1990 and 2010 (Murray et al.) . Thus the need for diagnostic tools that offer an early and individualised detection of liver cirrhosis is clearly evident.
The exhaled breath of liver cirrhosis sufferers was investigated in the ensuing study via a two-stage approach, with an initial discovery phase to seek potential breath biomarkers associated with the disease that was supplemented by a targeted phase to follow the identified markers during recovery progression after hepatic transplantation. Three compounds, namely methanol, 2-pentanone and limonene, correlated with liver disease and function, with elevated levels in the exhaled breath of cirrhotic patients compared to a healthy control group and a decreasing post-surgery trend that corresponded to the functional commencement of the transplanted organ. The data revealed a high diagnostic accuracy based on the area under the receiver operator characteristic (ROC) curve, with a sensitivity of 97% and a specificity of 70%.
The study is unique, not only due to its complementary (two-stage) approach, but because the cirrhosis-related breath volatiles discovered are, contradictorily, by no means unique, yet appear to reflect the functionality of the liver to a high degree. Most breath research focusses on searching for biomarkers generated by the illness, but rather than attributing these compounds to a production in the diseased liver, the authors hypothesise that their elevated concentrations in the breath of cirrhotic patients represent an accumulation in the body due to a lack of metabolic breakdown by the impaired liver. This very plausible explanation, which is supported by considerations on the biochemistry and physicochemical properties of these biomarkers, makes for a strong and compelling case on the potential utility of breath analysis in diagnosing liver cirrhosis and monitoring organ function after transplantation via these markers.
